Photobiomodulation Therapy Associated with Heterologous Fibrin Biopolymer and Bovine Bone Matrix Helps to Reconstruct Long Bones.

Bone defects cause aesthetic and functional changes that affect the social, economic and especially the emotional life of human beings. This complication stimulates the scientific community to investigate strategies aimed at improving bone reconstruction processes using complementary therapies. Photobiomodulation therapy (PBMT) and the use of new biomaterials, including heterologous fibrin biopolymer (HFB), are included in this challenge. The objective of the present study was to evaluate the influence of photobiomodulation therapy on bone tibial reconstruction of rats with biomaterial consisting of lyophilized bovine bone matrix (BM) associated or not with heterologous fibrin biopolymer. Thirty male rats were randomly separated into three groups of 10 animals. In all animals, after the anesthetic procedure, a noncritical tibial defect of 2 mm was performed. The groups received the following treatments: Group 1: BM + PBMT, Group 2: BM + HFB and Group 3: BM + HFB + PBMT. The animals from Groups 1 and 3 were submitted to PBMT in the immediate postoperative period and every 48 h until the day of euthanasia that occurred at 14 and 42 days. Analyses by computed microtomography (µCT) and histomorphometry showed statistical difference in the percentage of bone formation between Groups 3 (BM + HB + PBMT) and 2 (BM + HFB) (26.4% ± 1.03% and 20.0% ± 1.87%, respectively) at 14 days and at 42 days (38.2% ± 1.59% and 31.6% ± 1.33%, respectively), and at 42 days there was presence of bone with mature characteristics and organized connective tissue. The µCT demonstrated BM particles filling the defect and the deposition of new bone in the superficial region, especially in the ruptured cortical. It was concluded that the association of PBMT with HFB and BM has the potential to assist in the process of reconstructing bone defects in the tibia of rats.

Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review.

Fibrin biopolymers, previously referred as "fibrin glue" or "fibrin sealants", are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was "heterologous fibrin sealant". The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.

Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review

Fibrin biopolymers, previously referred as "fibrin glue" or "fibrin sealants", are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was "heterologous fibrin sealant". The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.(AU)

Estudo comparativo entre as técnicas de sutura término-lateral e coaptação com selante de fibrina na regeneração do nervo facial, associada ou não ao laser de baixa potência / Comparative study between the techniques of end-to-side suture and coaptation with fibrin sealant in the facial nerve regeneration, associated or not to the low-power laser

As lesões na face estão mais comuns na sociedade atual, envolvendo acidentes automobilísticos, quedas ou consequências iatrogênicas após procedimentos. Essas lesões podem afetar os nervos responsáveis pela musculatura facial repercutindo em alterações físicas, emocionais e psicossociais, por exemplo, no sistema estomatognático, na voz, na expressão e estética faciais, nos sentimentos e convívio social do indivíduo. Pesquisas atuais estão almejando melhores técnicas para o processo de reparo nervoso periférico e reabilitação funcional dessas lesões. As técnicas tradicionais como sutura epineural término-lateral e coaptação por meio de selante de fibrina são utilizadas com essa finalidade. O objetivo deste estudo foi avaliar a reparação do ramo bucal do nervo facial lesionado por meio da técnica términolateral de duas diferentes formas: sutura epineural e o novo selante heterólogo de fibrina, associadas ou não ao tratamento com laser de baixa potência. Foram utilizados trinta e dois ratos (Rattus norvegiccus, Wistar) com 80 dias de vida, distribuídos aleatoriamente em Grupo Controle (GC; n=8), e Grupos Experimentais (Grupo Experimental Sutura - GES e Grupo Experimental Fibrina – GEF; n=12; Grupo Experimental Sutura Laser – GESL e Grupo Experimental Fibrina Laser – GEFL; n=12). Os animais do GC não receberam intervenção cirúrgica; no GES foi realizado, no lado direito da face, a secção do ramo bucal do nervo facial, onde o coto proximal foi suturado à tela subcutânea e o coto distal suturado de forma término-lateral ao ramo zigomático do nervo facial; no GEF, no lado esquerdo da face, foram realizados os mesmos procedimentos do GES, porém foi utilizada a coaptação com selante de fibrina do coto distal. Os grupos GESL e GEFL, além das técnicas descritas, receberam tratamento com aplicação de Laser Arseneto de Gálio Alumínio (GaAlAs), pulso contínuo, comprimento de onda de 830 nm, 6 J/cm2, por 24 segundos, três vezes por semana durante cinco semanas, em três...

The injuries on the face are more common in today's society, involving motor vehicle accidents, falls or iatrogenic consequences after procedures. These injuries can affect the nerves responsible for facial muscles reflecting in physical, emotional and psychosocial changes, for example in the stomatognathic system, in voice, facial expression and aesthetics, feelings and social life of the individual. Current researches are aiming best techniques to the process of peripheral nerve repair and functional rehabilitation of these injuries. Traditional techniques such as end-to-side epineural suture coaptation by fibrin sealants are used for this purpose. The objective of this study was to evaluate the repair of buccal branch of the facial nerve injured by end-toside technique in two different ways: epineural suture and the new heterologous fibrin sealant, associated or not to treatment with low power laser. Thirty-two rats (Rattus norvegicus, Wistar) were used. They were 80 days old and were randomly divided into Control Group (CG, n=8) and Experimental Groups (Experimental Suture Group – ESG and Experimental Fibrin Group - EFG; n=12; Experimental Suture Laser Group – ESLG and Experimental Fibrin Laser Group - EFLG; n=12). The CG animals did not receive surgery; the ESG was performed on the right side of the face, the section of the buccal branch of the facial nerve, where the proximal stump was sutured to the subcutaneous tissue and the distal stump sutured end-to-side portion of the zygomatic branch of the facial nerve; EFG on the left side of the face, the same procedures were carried ESG, but was used coaptation with fibrin sealant of the distal stump. The groups ESLG and EFLG, and the techniques described, have been treated with the application of Laser Gallium Aluminum Arsenide (GaAlAs), continuous pulse, wave length 830 nm, 6J /cm2 for 24 seconds, three times per week for five weeks, at three points of the local operated from both sides. It also...